DSAEK Corneal Transplant
What Is DSAEK and How Does It Work
DSAEK, which stands for Descemet stripping automated endothelial keratoplasty, is a surgical technique designed to restore the inner pumping layer of the cornea without replacing the entire eye surface. It has become the standard of care for most forms of corneal endothelial failure because it combines precision with a shorter, more comfortable recovery than older full-thickness transplant methods.
The endothelium is a single layer of specialized pump cells that lines the inside of the cornea. These cells continuously remove fluid from the corneal tissue, keeping it thin and optically clear. When endothelial cells fail or die, fluid accumulates inside the cornea and it begins to swell and cloud. This swelling is what causes the blurred, foggy, and sometimes painful vision that brings patients to a cornea specialist.
Unlike a full-thickness transplant, DSAEK replaces only the diseased endothelial cell layer and a very thin supporting layer called Descemet's membrane. The donor graft tissue is prepared using an automated instrument called a microkeratome to ensure consistent thickness. Because the outer corneal layers remain untouched, the eye retains much of its original structure and strength.
Endothelial keratoplasty procedures, including DSAEK, have replaced full-thickness penetrating keratoplasty as the most commonly performed corneal transplant in the United States. DSAEK uses a small, self-sealing incision that does not require corneal sutures. This reduces the risk of complications tied to sutures, lowers the chance of irregular astigmatism after surgery, and allows vision to stabilize more quickly than with older techniques.
Conditions DSAEK Can Treat
DSAEK is used when the endothelium has failed or is failing, but the outer and middle layers of the cornea remain healthy enough to preserve. Our Cornea Specialists evaluate each patient carefully to confirm that endothelial replacement is the right solution before recommending surgery.
Fuchs' dystrophy is the most common reason patients need DSAEK. It is an inherited condition in which endothelial cells gradually deteriorate over time. Early symptoms often include blurred vision in the morning that improves later in the day as the cornea naturally dries out. As the disease progresses, swelling becomes persistent and vision loss, glare, and eye discomfort affect daily function. DSAEK can restore clear, comfortable vision for patients whose quality of life has been significantly impacted.
Some patients develop corneal swelling after cataract surgery, a condition called pseudophakic bullous keratopathy. This can happen when the endothelium was already weakened before surgery or was stressed during the procedure. Symptoms may appear weeks, months, or even years after the original operation. DSAEK restores pump function and clears the cornea in most cases.
DSAEK can also be performed when a previous transplant, whether full-thickness or endothelial, has stopped functioning. When only the pump layer has failed and the rest of the graft or native cornea remains intact, DSAEK is often an effective option. Success rates in repeat transplants are strong, though somewhat lower than in a first-time procedure, and our specialists discuss these expectations honestly before surgery.
Diagnostic Testing and the Consultation Visit
Before recommending DSAEK, our Cornea Specialists perform a thorough evaluation to confirm the diagnosis, measure the severity of endothelial damage, and identify any other eye conditions that could affect surgical outcomes. This visit is also a time to ask questions, understand the timeline, and plan for recovery.
Your consultation begins with a review of your symptoms, vision history, medications, and any family history of corneal disease. A slit-lamp exam, which uses a high-powered microscope to view the eye in detail, checks the cornea, iris, and lens. Your Cornea Specialist will walk through the risks, benefits, and expected timeline in straightforward terms, and will ask about your work, driving needs, and home support to help shape a realistic plan.
Several tests help our team understand the full picture of your corneal health before surgery.
- Specular microscopy counts your endothelial cells and evaluates their shape and density
- Pachymetry measures corneal thickness, which increases when swelling is present
- Optical coherence tomography creates detailed cross-sectional images of each corneal layer
Together, these tests confirm that the endothelium is the primary problem and rule out other conditions that could limit how well surgery works.
Patients with Fuchs' dystrophy often eventually need DSAEK in both eyes. Our standard approach is to treat one eye first and allow it to stabilize before operating on the other. This spacing preserves your ability to function during recovery and gives your care team clear information from the first surgery to guide the second. Your Cornea Specialist will recommend the appropriate interval based on your healing progress and symptoms in the untreated eye.
DSAEK Compared to DMEK
DMEK, or Descemet membrane endothelial keratoplasty, is a newer variation of endothelial transplant that uses an even thinner graft. Both procedures replace the same diseased cell layer, but they differ in visual outcomes, technical difficulty, and the types of eyes they work best in. Our Cornea Specialists help you understand which approach is best suited to your specific anatomy and needs.
DMEK often delivers slightly sharper final vision than DSAEK in straightforward cases, with a higher proportion of patients reaching 20/25 or better. However, ultrathin and nanothin DSAEK techniques, which use a thinner donor graft than traditional DSAEK, have narrowed that gap considerably. Most DSAEK patients reach 20/40 or better, and many achieve 20/25, with vision continuing to improve for three to six months after surgery.
DSAEK is generally preferred when the eye has a more complex anatomy that makes a very thin DMEK graft harder to position safely. Eyes with a prior glaucoma tube shunt, a significant iris defect, or a large pupil may be better served by the slightly thicker and more stable DSAEK graft. Your Cornea Specialist reviews your full eye history and anatomy to guide this decision.
Both DSAEK and DMEK carry some risk of graft dislocation, where the graft partially separates from the host cornea before it fully attaches. This is usually managed with a small air injection in clinic, a procedure called rebubbling, that repositions the graft without returning to the operating room. Dislocation requiring rebubbling occurs in a minority of endothelial keratoplasty cases and is most common in the first days after surgery.
The DSAEK Procedure Step by Step
DSAEK is performed as an outpatient surgery, meaning you go home the same day. Knowing what to expect before, during, and immediately after the procedure helps reduce anxiety and supports a smooth recovery.
Your surgical team will give you specific instructions about medications, eating, and what to bring on the day of the procedure. The donor corneal tissue is obtained from a certified eye bank and carefully screened for safety and quality before use. Arranging a driver, a light meal beforehand if permitted, and a quiet place to rest afterward are important parts of preparation.
DSAEK is performed under local anesthesia with sedation, so you are comfortable and relaxed but not under general anesthesia. Your surgeon makes a small, self-sealing incision at the edge of the cornea and gently removes the diseased endothelial layer. The donor graft, folded for easier insertion, is guided through the small opening and carefully unfolded inside the eye. A small bubble of air or gas is then placed to press the graft flat against the back surface of your cornea while it begins to attach.
After the procedure, you will rest in recovery for a short time before going home. Lying face-up for several hours is important during this period, as the air bubble needs to stay centered to hold the graft in position while it bonds. Eye drops begin the same day, and a protective shield is worn over the eye at night during the first week to prevent accidental contact during sleep.
Recovery and Long-Term Graft Care
DSAEK recovery is gradual, and most patients notice meaningful improvement within the first few weeks. Protecting the graft during early healing and maintaining regular follow-up over the long term are both essential to getting the best outcome from surgery.
Vision will be blurry at first as the graft settles against the cornea and the air bubble gradually absorbs. Eye drops, including antibiotic and steroid drops, begin on the first day and are an important part of protecting the new tissue. Patients are asked to avoid rubbing the eye, lifting heavy objects, and swimming during this period. A protective eye shield worn at night prevents unintentional pressure on the eye during sleep.
Vision typically begins to clear within the first one to two weeks as the graft attaches and corneal swelling decreases. Antibiotic drops are tapered and eventually stopped, while steroid drops continue at a gradually reduced frequency. Follow-up appointments during this period allow your Cornea Specialist to check graft position, measure eye pressure, and confirm that healing is progressing as expected.
Most patients reach their clearest, most stable vision somewhere between three and six months after surgery. As swelling fully resolves, a final glasses prescription can be determined. Some patients continue a low-dose steroid eye drop for a year or longer as an added layer of protection against rejection, based on their individual risk factors and their specialist's recommendation.
DSAEK grafts can remain clear and functional for many years with proper care. Annual exams allow your care team to monitor endothelial cell counts, graft clarity, and eye pressure over time. Early detection of any decline in cell health or early rejection signs makes treatment significantly more effective, which is why consistent long-term follow-up matters as much as the surgery itself.
Risks and Warning Signs to Know
Like all surgical procedures, DSAEK carries some risk. Understanding the most important warning signs and knowing when to contact your Cornea Specialist promptly can make a significant difference in protecting your graft and your vision.
Rejection occurs when the immune system identifies the donor tissue as foreign and begins attacking it. The most important warning signs are sudden new redness, pain, increased light sensitivity, or a noticeable drop in vision. Contact your care team immediately if any of these symptoms develop. Rejection caught early can often be reversed with intensive steroid eye drops, and the graft can be saved in many cases.
Serious eye infections after transplant surgery are rare but require urgent attention. Eye pain, worsening redness, and discharge that develops in the weeks after surgery should be evaluated promptly. Steroid drops used to prevent rejection can lower the eye's immune defenses, which is why your care team monitors for infection signs closely during follow-up visits.
Eye pressure can rise in the days after surgery due to the air bubble or as a side effect of steroid eye drops. Elevated pressure may cause a dull headache or a feeling of fullness in the eye. Your Cornea Specialist monitors pressure at each follow-up visit and adjusts drops or adds pressure-lowering medication when needed. Patients with a history of glaucoma require particularly close monitoring.
In patients who still have their natural lens, cataract formation or worsening can occur after surgery. Cystoid macular edema, a temporary swelling in the central retina, can also reduce vision in the weeks following the procedure. Both complications are typically manageable with prompt treatment. Consistent follow-up helps catch these issues at a stage when they respond well to care.
Frequently Asked Questions
These answers address practical questions about DSAEK that go beyond the general information covered above, including timing, insurance, and day-to-day guidance during recovery.
DSAEK typically takes 45 to 60 minutes in the operating room, but you should plan to be at the surgical facility for several hours total. That time includes check-in, pre-operative preparation such as dilating drops and IV placement for sedation, the procedure itself, and a brief recovery period before your driver takes you home. Bringing a book or music for the waiting periods is a practical idea.
Most patients still benefit from glasses after DSAEK, particularly for reading or fine detail. Because DSAEK targets the inner corneal layer rather than reshaping the front surface, distance prescriptions often do not shift dramatically. A final updated prescription is given once vision has fully stabilized, which is usually around three to six months after surgery. Your optometrist will work alongside your Cornea Specialist to fit your glasses at the right time.
Most patients are advised to avoid driving for at least one to two weeks after DSAEK, and your Cornea Specialist will confirm when your vision meets legal driving standards at a follow-up visit. Night driving often lags behind daytime vision by a few additional weeks as glare and halos gradually fade. Return to work depends on your job: desk work is typically possible within one to two weeks, while physically demanding jobs or dusty environments may require three to four weeks of recovery time. Your care team will give guidance specific to your situation.
DSAEK is considered a medically necessary procedure for vision-threatening corneal disease and is generally covered by major insurance plans, including Medicare and most commercial plans. Coverage details vary, and there may be out-of-pocket costs depending on your specific plan. Our team verifies your benefits before surgery and explains any anticipated costs clearly so there are no surprises.
Five-year graft survival rates for DSAEK in Fuchs' dystrophy are strong, with many grafts lasting a decade or more with good care. Outcomes are somewhat lower in eyes that have had prior transplants or in corneal swelling related to previous cataract surgery, and your Cornea Specialist will give you an honest picture of what to expect based on your specific diagnosis. Annual monitoring of endothelial cell counts is the most important factor in detecting any long-term graft changes before they affect vision.
Contact your care team immediately if you experience sudden new pain, redness, increased sensitivity to light, or a noticeable worsening of vision at any point during recovery. These symptoms can indicate rejection or infection, both of which respond much better to early treatment than to a wait-and-see approach. If symptoms appear after hours, go to the nearest emergency eye care facility rather than waiting for the next scheduled appointment.
Schedule a DSAEK Evaluation at Rhode Island Eye Institute
Our fellowship-trained Cornea Specialists, Drs. Jane Cook, Elliot Perlman, and Christopher Newton, bring decades of combined corneal surgery experience and academic leadership through Brown University to every patient evaluation. Whether you are newly diagnosed with Fuchs' dystrophy, dealing with vision loss after cataract surgery, or facing a failed prior graft, we are here to give you a clear, honest plan. Contact Rhode Island Eye Institute to schedule your consultation and take the first step toward clearer, more comfortable vision.